RedixFi
RedixFi

NEOGEN · Concall Summary

NEOGEN CHEMICALS LIMITED

Concall2026-08-01
Tone: Positive

Neogen Chemicals Limited held its Q1 FY27 earnings conference call on July 27, 2026, where management reported a strong performance with consolidated revenue of INR 250 crore, a 34% year-on-year increase. EBITDA rose by 53% to INR 48 crore, with margins expanding to 19.3%. The company highlighted resilience in its base business despite global supply chain challenges and elevated costs. Key updates included the near completion of the Dahej replacement plant, a planned INR 600 crore fundraising through a QIP, and significant growth in the battery chemicals segment, particularly Neogen Ionics, which generated INR 19 crore in revenue. Management expressed confidence in capturing market opportunities driven by government support for battery materials and projected domestic battery demand growth. They revised standalone revenue guidance for FY27 to INR 950-1,050 crore, reflecting optimism about operational improvements and market conditions.

Management emphasized strong financial performance and growth opportunities.

View source filing →

Earlier concalls

  • 2026-07-26Neogen Chemicals Limited's investor presentation detailed the company's unaudited financial results for the quarter ende
  • 2026-05-25Neogen Chemicals Limited held its Q4 FY26 earnings conference call on May 18, 2026, where management discussed the compa
  • 2026-05-17Neogen Chemicals Limited's investor presentation detailed the audited financial results for the quarter and financial ye

See NEOGEN's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.

Sign up free

Back to NEOGEN snapshot